25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Strides Pharma Science Ltd
Buy, Hold or Sell?

Let's analyze Strides together

I guess you are interested in Strides Pharma Science Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Strides Pharma Science Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Strides Pharma Science Ltd

I send you an email if I find something interesting about Strides Pharma Science Ltd.

1. Quick Overview

1.1. Quick analysis of Strides (30 sec.)










1.2. What can you expect buying and holding a share of Strides? (30 sec.)

How much money do you get?

How much money do you get?
INR0.07
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
INR225.29
Expected worth in 1 year
INR181.28
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
INR-38.13
Return On Investment
-2.5%

For what price can you sell your share?

Current Price per Share
INR1,555.30
Expected price per share
INR1,061 - INR1,675
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Strides (5 min.)




Live pricePrice per Share (EOD)
INR1,555.30
Intrinsic Value Per Share
INR28.08 - INR649.19
Total Value Per Share
INR253.36 - INR874.47

2.2. Growth of Strides (5 min.)




Is Strides growing?

Current yearPrevious yearGrowGrow %
How rich?$246.5m$258.5m-$12m-4.9%

How much money is Strides making?

Current yearPrevious yearGrowGrow %
Making money-$8.4m-$24.1m$15.7m187.0%
Net Profit Margin-1.7%-5.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Strides (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Strides?

Welcome investor! Strides's management wants to use your money to grow the business. In return you get a share of Strides.

First you should know what it really means to hold a share of Strides. And how you can make/lose money.

Speculation

The Price per Share of Strides is INR1,555. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Strides.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Strides, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR225.29. Based on the TTM, the Book Value Change Per Share is INR-11.00 per quarter. Based on the YOY, the Book Value Change Per Share is INR-22.88 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR1.47 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Strides.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps-0.090.0%-0.090.0%-0.260.0%-0.110.0%0.250.0%
Usd Book Value Change Per Share-0.130.0%-0.130.0%-0.270.0%-0.190.0%0.130.0%
Usd Dividend Per Share0.020.0%0.020.0%0.000.0%0.020.0%0.030.0%
Usd Total Gains Per Share-0.110.0%-0.110.0%-0.270.0%-0.170.0%0.160.0%
Usd Price Per Share9.31-9.31-3.41-6.15-8.08-
Price to Earnings Ratio-101.92--101.92--12.99--2.28-13.13-
Price-to-Total Gains Ratio-82.10--82.10--12.50--17.30-5.08-
Price to Book Ratio3.47-3.47-1.21-1.98-2.90-
Price-to-Total Gains Ratio-82.10--82.10--12.50--17.30-5.08-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share18.50807
Number of shares54
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share-0.13-0.19
Usd Total Gains Per Share-0.11-0.17
Gains per Quarter (54 shares)-6.13-9.02
Gains per Year (54 shares)-24.50-36.08
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
14-28-355-41-46
28-57-609-82-82
311-85-8514-122-118
415-113-11019-163-154
519-141-13524-204-190
623-170-16028-245-226
726-198-18533-286-262
830-226-21038-326-298
934-255-23543-367-334
1038-283-26047-408-370

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%7.03.00.070.0%8.03.00.072.7%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%5.05.00.050.0%6.05.00.054.5%
Dividend per Share1.00.00.0100.0%2.00.01.066.7%4.00.01.080.0%9.00.01.090.0%10.00.01.090.9%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%5.05.00.050.0%6.05.00.054.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Strides Pharma Science Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---11.002-11.0020%-22.884+108%-15.876+44%10.757-202%
Book Value Per Share--225.288225.2880%236.290-5%261.783-14%263.093-14%
Current Ratio--1.0311.0310%1.085-5%1.012+2%1.200-14%
Debt To Asset Ratio--0.6450.6450%0.673-4%0.631+2%0.622+4%
Debt To Equity Ratio--1.7731.7730%2.019-12%1.732+2%1.709+4%
Dividend Per Share--1.4701.4700%-+100%1.841-20%2.578-43%
Eps---7.679-7.6790%-22.036+187%-9.322+21%20.811-137%
Free Cash Flow Per Share--63.38963.3890%-5.495+109%8.046+688%-10.476+117%
Free Cash Flow To Equity Per Share--63.38963.3890%-5.495+109%-20.314+132%-2.477+104%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--649.187--------
Intrinsic Value_10Y_min--28.077--------
Intrinsic Value_1Y_max--20.382--------
Intrinsic Value_1Y_min---7.198--------
Intrinsic Value_3Y_max--95.284--------
Intrinsic Value_3Y_min---13.084--------
Intrinsic Value_5Y_max--211.231--------
Intrinsic Value_5Y_min---9.562--------
Market Cap143022588460.000+50%71966487320.00071966487320.0000%26313838930.000+173%47493651554.000+52%62470196660.246+15%
Net Profit Margin---0.017-0.0170%-0.055+215%-0.026+48%0.107-116%
Operating Margin----0%0.039-100%0.046-100%0.074-100%
Operating Ratio--1.2761.2760%1.390-8%1.375-7%1.377-7%
Pb Ratio6.904+50%3.4743.4740%1.211+187%1.985+75%2.897+20%
Pe Ratio-202.541-99%-101.915-101.9150%-12.986-87%-2.278-98%13.130-876%
Price Per Share1555.300+50%782.600782.6000%286.150+173%516.470+52%679.333+15%
Price To Free Cash Flow Ratio24.536+50%12.34612.3460%-52.079+522%9.736+27%-11.237+191%
Price To Total Gains Ratio-163.156-99%-82.097-82.0970%-12.505-85%-17.302-79%5.078-1717%
Quick Ratio--0.4850.4850%0.4860%0.444+9%0.595-18%
Return On Assets---0.012-0.0120%-0.031+152%-0.013+7%0.048-125%
Return On Equity---0.033-0.0330%-0.092+176%-0.042+26%0.111-130%
Total Gains Per Share---9.533-9.5330%-22.884+140%-14.035+47%13.336-171%
Usd Book Value--246533014.000246533014.0000%258573077.000-5%286470175.600-14%287903530.600-14%
Usd Book Value Change Per Share---0.131-0.1310%-0.272+108%-0.189+44%0.128-202%
Usd Book Value Per Share--2.6812.6810%2.812-5%3.115-14%3.131-14%
Usd Dividend Per Share--0.0170.0170%-+100%0.022-20%0.031-43%
Usd Eps---0.091-0.0910%-0.262+187%-0.111+21%0.248-137%
Usd Free Cash Flow--69366766.00069366766.0000%-6012713.000+109%8804262.600+688%-11463448.500+117%
Usd Free Cash Flow Per Share--0.7540.7540%-0.065+109%0.096+688%-0.125+117%
Usd Free Cash Flow To Equity Per Share--0.7540.7540%-0.065+109%-0.242+132%-0.029+104%
Usd Market Cap1701968802.674+50%856401199.108856401199.1080%313134683.267+173%565174453.493+52%743395340.257+15%
Usd Price Per Share18.508+50%9.3139.3130%3.405+173%6.146+52%8.084+15%
Usd Profit---8403066.000-8403066.0000%-24113565.000+187%-10201322.600+21%22725810.800-137%
Usd Revenue--482083756.000482083756.0000%438918053.000+10%397939927.000+21%358340880.100+35%
Usd Total Gains Per Share---0.113-0.1130%-0.272+140%-0.167+47%0.159-171%
 EOD+4 -4MRQTTM+0 -0YOY+25 -105Y+23 -1210Y+11 -24

3.3 Fundamental Score

Let's check the fundamental score of Strides Pharma Science Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-202.541
Price to Book Ratio (EOD)Between0-16.904
Net Profit Margin (MRQ)Greater than0-0.017
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.485
Current Ratio (MRQ)Greater than11.031
Debt to Asset Ratio (MRQ)Less than10.645
Debt to Equity Ratio (MRQ)Less than11.773
Return on Equity (MRQ)Greater than0.15-0.033
Return on Assets (MRQ)Greater than0.05-0.012
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Strides Pharma Science Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.779
Ma 20Greater thanMa 501,539.165
Ma 50Greater thanMa 1001,427.759
Ma 100Greater thanMa 2001,222.598
OpenGreater thanClose1,556.050
Total5/5 (100.0%)

4. In-depth Analysis

4.1 About Strides Pharma Science Ltd

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.

Fundamental data was last updated by Penke on 2024-10-17 01:48:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Strides earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Strides to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -1.7% means that ₹-0.02 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Strides Pharma Science Ltd:

  • The MRQ is -1.7%. The company is making a loss. -1
  • The TTM is -1.7%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-1.7%TTM-1.7%0.0%
TTM-1.7%YOY-5.5%+3.8%
TTM-1.7%5Y-2.6%+0.8%
5Y-2.6%10Y10.7%-13.3%
4.3.1.2. Return on Assets

Shows how efficient Strides is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Strides to the Drug Manufacturers - Specialty & Generic industry mean.
  • -1.2% Return on Assets means that Strides generated ₹-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Strides Pharma Science Ltd:

  • The MRQ is -1.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.2%TTM-1.2%0.0%
TTM-1.2%YOY-3.1%+1.8%
TTM-1.2%5Y-1.3%+0.1%
5Y-1.3%10Y4.8%-6.1%
4.3.1.3. Return on Equity

Shows how efficient Strides is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Strides to the Drug Manufacturers - Specialty & Generic industry mean.
  • -3.3% Return on Equity means Strides generated ₹-0.03 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Strides Pharma Science Ltd:

  • The MRQ is -3.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -3.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.3%TTM-3.3%0.0%
TTM-3.3%YOY-9.2%+5.8%
TTM-3.3%5Y-4.2%+0.9%
5Y-4.2%10Y11.1%-15.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Strides Pharma Science Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Strides is operating .

  • Measures how much profit Strides makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Strides to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Strides Pharma Science Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY3.9%-3.9%
TTM-5Y4.6%-4.6%
5Y4.6%10Y7.4%-2.8%
4.3.2.2. Operating Ratio

Measures how efficient Strides is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.28 means that the operating costs are ₹1.28 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Strides Pharma Science Ltd:

  • The MRQ is 1.276. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.276. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.276TTM1.2760.000
TTM1.276YOY1.390-0.114
TTM1.2765Y1.375-0.099
5Y1.37510Y1.377-0.002
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Strides Pharma Science Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Strides is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.03 means the company has ₹1.03 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Strides Pharma Science Ltd:

  • The MRQ is 1.031. The company is just able to pay all its short-term debts.
  • The TTM is 1.031. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.031TTM1.0310.000
TTM1.031YOY1.085-0.053
TTM1.0315Y1.012+0.019
5Y1.01210Y1.200-0.187
4.4.3.2. Quick Ratio

Measures if Strides is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Strides to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.49 means the company can pay off ₹0.49 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Strides Pharma Science Ltd:

  • The MRQ is 0.485. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.485. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.485TTM0.4850.000
TTM0.485YOY0.486-0.001
TTM0.4855Y0.444+0.041
5Y0.44410Y0.595-0.151
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Strides Pharma Science Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Strides assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Strides to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.65 means that Strides assets are financed with 64.5% credit (debt) and the remaining percentage (100% - 64.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Strides Pharma Science Ltd:

  • The MRQ is 0.645. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.645. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.645TTM0.6450.000
TTM0.645YOY0.673-0.027
TTM0.6455Y0.631+0.015
5Y0.63110Y0.622+0.009
4.5.4.2. Debt to Equity Ratio

Measures if Strides is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Strides to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 177.3% means that company has ₹1.77 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Strides Pharma Science Ltd:

  • The MRQ is 1.773. The company is just able to pay all its debts with equity.
  • The TTM is 1.773. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.773TTM1.7730.000
TTM1.773YOY2.019-0.246
TTM1.7735Y1.732+0.041
5Y1.73210Y1.709+0.023
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Strides generates.

  • Above 15 is considered overpriced but always compare Strides to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -101.92 means the investor is paying ₹-101.92 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Strides Pharma Science Ltd:

  • The EOD is -202.541. Based on the earnings, the company is expensive. -2
  • The MRQ is -101.915. Based on the earnings, the company is expensive. -2
  • The TTM is -101.915. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-202.541MRQ-101.915-100.626
MRQ-101.915TTM-101.9150.000
TTM-101.915YOY-12.986-88.929
TTM-101.9155Y-2.278-99.637
5Y-2.27810Y13.130-15.408
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Strides Pharma Science Ltd:

  • The EOD is 24.536. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 12.346. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 12.346. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD24.536MRQ12.346+12.190
MRQ12.346TTM12.3460.000
TTM12.346YOY-52.079+64.425
TTM12.3465Y9.736+2.610
5Y9.73610Y-11.237+20.974
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Strides is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 3.47 means the investor is paying ₹3.47 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Strides Pharma Science Ltd:

  • The EOD is 6.904. Based on the equity, the company is overpriced. -1
  • The MRQ is 3.474. Based on the equity, the company is fair priced.
  • The TTM is 3.474. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD6.904MRQ3.474+3.430
MRQ3.474TTM3.4740.000
TTM3.474YOY1.211+2.263
TTM3.4745Y1.985+1.489
5Y1.98510Y2.897-0.912
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets58,397,550
Total Liabilities37,680,490
Total Stockholder Equity21,255,630
 As reported
Total Liabilities 37,680,490
Total Stockholder Equity+ 21,255,630
Total Assets = 58,397,550

Assets

Total Assets58,397,550
Total Current Assets29,689,990
Long-term Assets28,707,560
Total Current Assets
Cash And Cash Equivalents 1,610,200
Short-term Investments 2,554,110
Net Receivables 11,418,740
Inventory 11,262,400
Other Current Assets 2,717,200
Total Current Assets  (as reported)29,689,990
Total Current Assets  (calculated)29,562,650
+/- 127,340
Long-term Assets
Property Plant Equipment 9,585,460
Goodwill 5,294,110
Intangible Assets 5,271,150
Long-term Assets Other 242,540
Long-term Assets  (as reported)28,707,560
Long-term Assets  (calculated)20,393,260
+/- 8,314,300

Liabilities & Shareholders' Equity

Total Current Liabilities28,792,590
Long-term Liabilities8,887,900
Total Stockholder Equity21,255,630
Total Current Liabilities
Short Long Term Debt 17,430,260
Accounts payable 8,515,910
Other Current Liabilities 689,170
Total Current Liabilities  (as reported)28,792,590
Total Current Liabilities  (calculated)26,635,340
+/- 2,157,250
Long-term Liabilities
Long term Debt 6,714,990
Capital Lease Obligations Min Short Term Debt1,023,400
Long-term Liabilities  (as reported)8,887,900
Long-term Liabilities  (calculated)7,738,390
+/- 1,149,510
Total Stockholder Equity
Total Stockholder Equity (as reported)21,255,630
Total Stockholder Equity (calculated)0
+/- 21,255,630
Other
Capital Stock919,000
Common Stock Shares Outstanding 91,900
Net Debt 22,535,050
Net Invested Capital 45,400,880
Net Working Capital 897,400
Property Plant and Equipment Gross 9,585,460



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
20,990,190
24,747,460
74,559,130
81,167,700
65,437,440
80,055,090
61,517,330
70,150,200
69,758,620
66,384,200
58,397,550
58,397,55066,384,20069,758,62070,150,20061,517,33080,055,09065,437,44081,167,70074,559,13024,747,46020,990,190
   > Total Current Assets 
13,086,340
14,294,450
35,148,940
37,918,200
24,835,910
30,487,220
23,721,110
28,172,340
33,618,310
32,433,610
29,689,990
29,689,99032,433,61033,618,31028,172,34023,721,11030,487,22024,835,91037,918,20035,148,94014,294,45013,086,340
       Cash And Cash Equivalents 
2,311,450
1,468,850
3,115,880
3,221,270
2,559,620
3,656,890
1,822,340
1,258,340
1,707,300
3,035,010
1,610,200
1,610,2003,035,0101,707,3001,258,3401,822,3403,656,8902,559,6203,221,2703,115,8801,468,8502,311,450
       Short-term Investments 
4,012,370
5,612,890
0
12,866,880
3,517,970
4,266,810
1,655,970
1,490,320
134,550
1,550,820
2,554,110
2,554,1101,550,820134,5501,490,3201,655,9704,266,8103,517,97012,866,88005,612,8904,012,370
       Net Receivables 
4,628,070
4,672,510
12,374,630
11,499,210
9,756,070
11,222,310
9,316,940
11,105,870
12,073,010
12,994,020
11,418,740
11,418,74012,994,02012,073,01011,105,8709,316,94011,222,3109,756,07011,499,21012,374,6304,672,5104,628,070
       Inventory 
1,759,900
2,076,760
6,131,370
7,328,000
5,520,240
8,741,580
7,825,390
12,007,030
11,737,960
11,465,050
11,262,400
11,262,40011,465,05011,737,96012,007,0307,825,3908,741,5805,520,2407,328,0006,131,3702,076,7601,759,900
       Other Current Assets 
265,980
276,150
1,163,830
2,830,460
3,161,580
2,241,870
2,151,530
1,375,850
1,476,180
2,713,920
2,717,200
2,717,2002,713,9201,476,1801,375,8502,151,5302,241,8703,161,5802,830,4601,163,830276,150265,980
   > Long-term Assets 
0
0
0
43,001,030
40,601,530
49,602,460
37,796,220
41,952,080
36,114,530
33,950,590
28,707,560
28,707,56033,950,59036,114,53041,952,08037,796,22049,602,46040,601,53043,001,030000
       Property Plant Equipment 
4,383,190
5,811,740
12,348,520
11,828,000
9,868,150
11,369,060
14,639,390
14,994,470
15,136,440
13,725,520
9,585,460
9,585,46013,725,52015,136,44014,994,47014,639,39011,369,0609,868,15011,828,00012,348,5205,811,7404,383,190
       Goodwill 
1,033,950
1,368,370
9,267,160
9,669,500
9,147,090
13,691,110
4,285,580
4,805,400
4,859,070
5,137,580
5,294,110
5,294,1105,137,5804,859,0704,805,4004,285,58013,691,1109,147,0909,669,5009,267,1601,368,3701,033,950
       Long Term Investments 
418,040
687,560
525,020
2,450,650
2,781,300
4,193,130
0
0
0
0
0
000004,193,1302,781,3002,450,650525,020687,560418,040
       Intangible Assets 
1,122,810
1,545,190
13,319,820
15,435,730
14,537,790
15,646,600
5,462,980
6,185,110
6,249,820
5,630,930
5,271,150
5,271,1505,630,9306,249,8206,185,1105,462,98015,646,60014,537,79015,435,73013,319,8201,545,1901,122,810
       Long-term Assets Other 
0
0
0
22,060
22,220
19,010
0
249,480
104,820
265,260
242,540
242,540265,260104,820249,480019,01022,22022,060000
> Total Liabilities 
10,165,250
13,111,150
47,478,340
52,423,350
39,345,350
52,038,510
35,570,780
42,010,180
45,925,460
44,655,370
37,680,490
37,680,49044,655,37045,925,46042,010,18035,570,78052,038,51039,345,35052,423,35047,478,34013,111,15010,165,250
   > Total Current Liabilities 
7,073,720
10,199,400
18,919,850
31,038,690
18,993,030
26,622,400
25,448,570
27,383,480
34,116,750
29,902,010
28,792,590
28,792,59029,902,01034,116,75027,383,48025,448,57026,622,40018,993,03031,038,69018,919,85010,199,4007,073,720
       Short-term Debt 
5,466,160
4,212,880
2,119,320
20,885,520
9,665,800
14,126,300
0
0
0
0
0
0000014,126,3009,665,80020,885,5202,119,3204,212,8805,466,160
       Short Long Term Debt 
5,466,160
4,212,880
2,119,320
20,885,520
9,665,800
14,126,300
13,578,300
12,208,100
19,563,370
16,346,670
17,430,260
17,430,26016,346,67019,563,37012,208,10013,578,30014,126,3009,665,80020,885,5202,119,3204,212,8805,466,160
       Accounts payable 
2,623,060
2,344,100
7,753,960
7,740,940
7,120,690
8,889,880
7,977,480
11,342,000
10,715,240
9,823,430
8,515,910
8,515,9109,823,43010,715,24011,342,0007,977,4808,889,8807,120,6907,740,9407,753,9602,344,1002,623,060
       Other Current Liabilities 
1,523,450
1,450,240
1,611,050
1,495,210
1,505,960
2,281,470
2,988,140
2,169,860
2,024,240
1,930,980
689,170
689,1701,930,9802,024,2402,169,8602,988,1402,281,4701,505,9601,495,2101,611,0501,450,2401,523,450
   > Long-term Liabilities 
0
0
0
22,021,420
20,352,320
25,005,810
10,122,210
14,626,700
11,808,710
14,753,360
8,887,900
8,887,90014,753,36011,808,71014,626,70010,122,21025,005,81020,352,32022,021,420000
       Capital Lease Obligations 
0
0
0
118,350
125,330
107,010
2,729,250
2,448,370
2,330,650
2,551,130
1,023,400
1,023,4002,551,1302,330,6502,448,3702,729,250107,010125,330118,350000
       Long-term Liabilities Other 
0
0
0
47,450
6,570
6,380
3,380
1,080
16,040
18,280
0
018,28016,0401,0803,3806,3806,57047,450000
> Total Stockholder Equity
10,068,260
11,449,220
26,578,680
27,104,450
24,545,610
26,487,040
25,274,170
27,766,610
23,592,280
22,122,580
21,255,630
21,255,63022,122,58023,592,28027,766,61025,274,17026,487,04024,545,61027,104,45026,578,68011,449,22010,068,260
   Common Stock
595,660
596,160
893,460
894,230
895,000
895,490
895,650
896,810
897,900
0
0
00897,900896,810895,650895,490895,000894,230893,460596,160595,660
   Retained Earnings Total Equity00000000000
   Accumulated Other Comprehensive Income 00000000000
   Capital Surplus 00000000000
   Treasury Stock00000000000
   Other Stockholders Equity 
5,430,260
5,265,100
4,254,030
1,559,110
1,447,750
803,840
1,015,640
731,940
1,312,460
1,638,060
0
01,638,0601,312,460731,9401,015,640803,8401,447,7501,559,1104,254,0305,265,1005,430,260



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue40,511,240
Cost of Revenue-16,405,050
Gross Profit24,106,19024,106,190
 
Operating Income (+$)
Gross Profit24,106,190
Operating Expense-35,285,430
Operating Income5,225,810-11,179,240
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense35,285,4300
 
Net Interest Income (+$)
Interest Income0
Interest Expense-3,144,450
Other Finance Cost-0
Net Interest Income-3,144,450
 
Pretax Income (+$)
Operating Income5,225,810
Net Interest Income-3,144,450
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,169,4405,225,810
EBIT - interestExpense = -3,144,450
-706,140
2,438,310
Interest Expense3,144,450
Earnings Before Interest and Taxes (EBIT)01,975,010
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-1,169,440
Tax Provision-315,900
Net Income From Continuing Ops-1,485,340-1,485,340
Net Income-706,140
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net03,144,450
 

Technical Analysis of Strides
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Strides. The general trend of Strides is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Strides's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Strides Pharma Science Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1,675.

The bearish price targets are: 1,266 > 1,255 > 1,061.

Tweet this
Strides Pharma Science Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Strides Pharma Science Ltd. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Strides Pharma Science Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Strides Pharma Science Ltd. The current macd is 34.49.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Strides price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Strides. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Strides price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Strides Pharma Science Ltd Daily Moving Average Convergence/Divergence (MACD) ChartStrides Pharma Science Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Strides Pharma Science Ltd. The current adx is 23.43.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Strides shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Strides Pharma Science Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Strides Pharma Science Ltd. The current sar is 1,615.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Strides Pharma Science Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Strides Pharma Science Ltd. The current rsi is 58.78. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Strides Pharma Science Ltd Daily Relative Strength Index (RSI) ChartStrides Pharma Science Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Strides Pharma Science Ltd. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Strides price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Strides Pharma Science Ltd Daily Stochastic Oscillator ChartStrides Pharma Science Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Strides Pharma Science Ltd. The current cci is 3.71464132.

Strides Pharma Science Ltd Daily Commodity Channel Index (CCI) ChartStrides Pharma Science Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Strides Pharma Science Ltd. The current cmo is 14.45.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Strides Pharma Science Ltd Daily Chande Momentum Oscillator (CMO) ChartStrides Pharma Science Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Strides Pharma Science Ltd. The current willr is -60.24610748.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Strides is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Strides Pharma Science Ltd Daily Williams %R ChartStrides Pharma Science Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Strides Pharma Science Ltd.

Strides Pharma Science Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Strides Pharma Science Ltd. The current atr is 70.40.

Strides Pharma Science Ltd Daily Average True Range (ATR) ChartStrides Pharma Science Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Strides Pharma Science Ltd. The current obv is 4,893,049.

Strides Pharma Science Ltd Daily On-Balance Volume (OBV) ChartStrides Pharma Science Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Strides Pharma Science Ltd. The current mfi is 67.71.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Strides Pharma Science Ltd Daily Money Flow Index (MFI) ChartStrides Pharma Science Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Strides Pharma Science Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-06-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-06-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-20MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-06-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-06-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-16ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Strides Pharma Science Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Strides Pharma Science Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.779
Ma 20Greater thanMa 501,539.165
Ma 50Greater thanMa 1001,427.759
Ma 100Greater thanMa 2001,222.598
OpenGreater thanClose1,556.050
Total5/5 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Strides with someone you think should read this too:
  • Are you bullish or bearish on Strides? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Strides? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Strides Pharma Science Ltd

I send you an email if I find something interesting about Strides Pharma Science Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Strides Pharma Science Ltd.

Receive notifications about Strides Pharma Science Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.